Healthcare Innovations, 12
Back to All Secondary TrustsPortfolio Holdings by Security (As of Deposit Date)
Ticker | Security Description | Deposit % |
---|---|---|
ACAD | ACADIA Pharmaceuticals Inc. | 3.39 |
ARCT | Arcturus Therapeutics Holdings Inc. | 3.40 |
ARQT | Arcutis Biotherapeutics, Inc. | 3.34 |
ATRA | Atara Biotherapeutics, Inc. | 3.32 |
AVXL | Anavex Life Sciences Corp. | 3.40 |
AXSM | Axsome Therapeutics, Inc. | 3.26 |
BLUE | bluebird bio, Inc. | 3.32 |
BYSI | BeyondSpring Inc. | 3.35 |
CCXI | ChemoCentryx, Inc. | 3.29 |
DCPH | Deciphera Pharmaceuticals, Inc. | 3.28 |
DRNA | Dicerna Pharmaceuticals, Inc. | 3.33 |
ENTA | Enanta Pharmaceuticals, Inc. | 3.30 |
GBT | Global Blood Therapeutics, Inc. | 3.37 |
HRMY | Harmony Biosciences Holdings, Inc. | 3.38 |
IMGN | ImmunoGen, Inc. | 3.35 |
IMVT | Immunovant, Inc. | 3.37 |
INO | Inovio Pharmaceuticals, Inc. | 3.36 |
INSM | Insmed Incorporated | 3.39 |
IOVA | Iovance Biotherapeutics, Inc. | 3.27 |
KRYS | Krystal Biotech, Inc. | 3.22 |
MDGL | Madrigal Pharmaceuticals, Inc. | 3.33 |
MYOV | Myovant Sciences Ltd. | 3.35 |
NKTR | Nektar Therapeutics | 3.35 |
PHAT | Phathom Pharmaceuticals, Inc. | 3.23 |
RETA | Reata Pharmaceuticals, Inc. | 3.40 |
RGNX | REGENXBIO Inc. | 3.36 |
SAGE | Sage Therapeutics, Inc. | 3.33 |
TGTX | TG Therapeutics, Inc. | 3.34 |
TRIL | Trillium Therapeutics Inc. | 3.31 |
TVTX | Travere Therapeutics, Inc. | 3.31 |
Health Care
Ticker | Security Description | Deposit % |
---|---|---|
ACAD | ACADIA Pharmaceuticals Inc. | 3.39 |
AVXL | Anavex Life Sciences Corp. | 3.40 |
ARCT | Arcturus Therapeutics Holdings Inc. | 3.40 |
ARQT | Arcutis Biotherapeutics, Inc. | 3.34 |
ATRA | Atara Biotherapeutics, Inc. | 3.32 |
AXSM | Axsome Therapeutics, Inc. | 3.26 |
BYSI | BeyondSpring Inc. | 3.35 |
BLUE | bluebird bio, Inc. | 3.32 |
CCXI | ChemoCentryx, Inc. | 3.29 |
DCPH | Deciphera Pharmaceuticals, Inc. | 3.28 |
DRNA | Dicerna Pharmaceuticals, Inc. | 3.33 |
ENTA | Enanta Pharmaceuticals, Inc. | 3.30 |
GBT | Global Blood Therapeutics, Inc. | 3.37 |
HRMY | Harmony Biosciences Holdings, Inc. | 3.38 |
IMGN | ImmunoGen, Inc. | 3.35 |
IMVT | Immunovant, Inc. | 3.37 |
INO | Inovio Pharmaceuticals, Inc. | 3.36 |
INSM | Insmed Incorporated | 3.39 |
IOVA | Iovance Biotherapeutics, Inc. | 3.27 |
KRYS | Krystal Biotech, Inc. | 3.22 |
MDGL | Madrigal Pharmaceuticals, Inc. | 3.33 |
MYOV | Myovant Sciences Ltd. | 3.35 |
NKTR | Nektar Therapeutics | 3.35 |
PHAT | Phathom Pharmaceuticals, Inc. | 3.23 |
RETA | Reata Pharmaceuticals, Inc. | 3.40 |
RGNX | REGENXBIO Inc. | 3.36 |
SAGE | Sage Therapeutics, Inc. | 3.33 |
TGTX | TG Therapeutics, Inc. | 3.34 |
TVTX | Travere Therapeutics, Inc. | 3.31 |
TRIL | Trillium Therapeutics Inc. | 3.31 |
Summary
Description
-
Trust Name Healthcare Innovations, 12
-
Trust Symbol SMHCLX
-
MS Symbol STHC12
Deposit Data
-
Deposit Date 11/02/2021
-
Termination Date 20231102
-
Minimum Investment 100
-
Distribution Frequency Monthly (if any)
-
Initial Public Offer Price $10.00
-
Historical 12-Month Dist.* 0.0000
CUSIP
-
Cash Cusip 83192X747
-
Reinvest Cusip 83192X754
-
Fee Cash Cusip 83192X762
-
Fee Invest Cusip 83192X770
Documents
*The Historical 12-Month Distribution of Trust Holdings is as of 10/01/2024. If the Trust deposited after, or 90 days prior to, 10/01/2024, the distribution is as of deposit date. The Historical 12-Month Distribution is calculated by taking the weighted average of the regular income distributions paid by the securities included in the trust’s portfolio over the 12 months preceding the trust’s date of deposit reduced to account for the effects of trust fees and expenses. This historical distribution is for illustrative purposes only and is not indicative of amounts that will actually be distributed by the trust. The distributions paid by the trust may be higher or lower than the amount shown above due to factors including, but not limited to, changes in the price of trust units, changes (including reductions) in distributions paid by issuers, changes in actual trust expenses and sales of securities in the portfolio. There is no guarantee that the issuers of the securities included in the trust will pay any distributions in the future.